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Abstract
Background: There is ample evidence that since the turn of the millennium German health policy made a considerable 
step towards prevention and health promotion, putting the strategies of ‘personal empowerment’ and ‘settings based 
approach’ high on the federal government’s agenda. This phenomenon has challenged the role of ethics in health policy. 
Concurrently, increasing relevance of the Concept of Human Dignity for health and human rights has been discussed. 
However, a direct relationship between Human Dignity and Public Health Ethics (PHE) has surprisingly not yet been 
established. 
Methods: We here conduct a systematic ethical analysis of eminent German health prevention policy case-examples 
between the years 2000–2016. Specifically, our analysis seeks to adapt and apply the principalism (autonomy, 
beneficence, justice)-based Concept of Human Dignity of Italian philosopher Corrado Viafora, contextualizing it with 
the emerging field of PHE. To further inform this health policy analysis, index databases (PubMed, Google Scholar) 
were searched to include relevant published and grey literature. 
Results: We observe a systematic approach of post-millennial health policy decisions on prevention and on defined 
health targets in Germany, exemplified by (1) the fostering of the preparedness against pandemic infectious diseases, 
(2) the development and implementation of the first cancer vaccination, (3) major legal provisions on non-smokers 
protection in the public domain, (4) acts to strengthen long term care (LTC) as well as (5) the new German E-Health 
legislation. The ethical analysis of these health prevention decisions exhibits their profound ongoing impact on social 
justice, probing their ability to meet the underlying Concept of Human Dignity in order to fulfill the requirements of 
the principle of non-maleficence. 
Conclusion: The observed health policy focus on prevention and health promotion has sparked new public debates 
about the formation of/compliance with emerging standards of PHE in Germany. We believe that the overall impact of 
this novel policy orientation will gradually show over mid- and long-term periods, both in terms of improvements in 
health system performance and concurrently in diagnostics, therapies and health outcome on individual patient level. 
The Concept of Human Dignity may soon play an even greater role in European PHE debates to come.
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Introduction 
Over the last one and a half decades, prevention and health 
promotion have become leading public health policy topics 
that have been put forward high on the political agenda by 
many states and supranational organizations, eg, the European 
Union (EU)1 and the United Nations (UN), including the 
World Health Organization (WHO).2 Thus, public health 
issues and social determinants of health in Europe and at the 
global level have only recently appeared to become the focus 
of bioethical consideration.3 Given the financial constraints of 
states in economic crises and associated weaknesses in their 
social systems, states are increasingly aiming at sustainable 
policies for prevention and health promotion while striving 
to achieve more efficient overall health performance.4
These political efforts make up a constantly growing bulk of 
the agenda of governmental health policies, as demographic 
developments in many countries have resulted in a relative 
lack of the younger working population needed to support 
the states’ tax basis and statutory or private health insurance 
incomes.5 Furthermore, the gradual development of over-
ageing societies in Western and Far East countries, in 
conjunction with a foreseeable workforce shortage in the near 
future, require additional measures to keep the experienced 
and well-trained elderly in economic production.6 Prevention 
has thus also become an increasingly high priority topic for the 
industry, the labor market and the economy. Consequently, in 
the Western world and in Far East countries, a clear tendency 
towards enhancement of preventive policies, supported by 
governments and national economies, can be observed. For 
Germany, the OECD Health at a Glance Europe Report shows 
an increased life expectancy average of 81 years (2012), and, 
concurrently, an activity limitation starting already around 
the age of 60 in both sexes.7 In addition, a “self reported 
limitation in usual activities” was observed in Germany in 
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Implications for policy makers
• In times of rapid demographic change and globalization, public health and prevention strategies are increasingly seen as indispensable for 
effective and durable health policy solutions needed to manage unprecedented recurring national and global challenges nowadays faced by 
healthcare systems. 
• As most major health policy decisions, particularly in cases of prevention, will affect individual citizens’ lives in complex direct and indirect 
ethically sensitive ways, health policy stakeholders are increasingly confronted with a duty to evaluate and justify their decisions on grounds of 
frameworks of public health ethics (PHE).
• It should be acknowledged that the development and application of biomedical science in society in the past has been strongly guided and 
fostered by biomedical ethics, chiefly on grounds of human rights and especially on human dignity.
• In modern, multicultural, often partly secularized societies human dignity has the potential to serve as most valuable ethical baseline for public 
health policy decisions.
• In analyzing five major public health policy decisions of the last one and a half decades in Germany, human dignity proves to be a leading 
parameter in PHE, a concept that should be adopted by future public health policy legislative processes.
Implications for the public
Health policy’s major decisions, such as Acts on E-Health or Prevention, can hugely impact society, and thus should be considered and debated by 
the public with at least equal importance as legislative decisions pertaining to novel biomedical (so-called hot) technologies, like preimplantation 
genetic diagnosis or personalized nanomedicine. However, this is currently not the case for debates about public health regulations in the important 
field of prevention and health promotion. Thus, public societal debates on public health policy legislation and associated ethical implications should 
be encouraged, prompting a need for the application of common principles for well-reflected public health ethics (PHE) discourses. In our view, 
modern societies would greatly benefit from the Concept of Human Dignity as a common denominator to guide analysis and reflection upon critical 
ethical aspects in public health policy decisions. While providing a sound structural framework for ethical debate, this concept has the potential to 
empower individual citizens to actively participate in public ethical and political debates.
Key Messages 
over a third (34,1%) of the population above 16 years of age.7 
Thus, effective prevention of diseases appears to be more 
critical than ever to produce more healthy life years (HLY). It 
is the task of health policy to establish and promote conditions 
capable of reducing unnecessary suffering of a state’s citizens. 
In this context, and particularly over the past one and a half 
decades, evidence based health policy and public health ethics 
(PHE) have evolved as new fields of increasing scientific and 
sociopolitical interest.8
Viafora’s Methodology for Ethical Analysis of Clinical Practice: 
A Role for Emerging Public Health Ethics?
Around the turn of the millennium, and parallel to the rise 
of novel preventive health policy approaches, Human Dignity 
started to become a focus of healthcare professionals, lawyers, 
philosophers, bioethicists and politicians.9 Despite this fact, 
the Concept of Human Dignity has also been disputed; some 
authors have even denied its usefulness in ethical guidance,10,11 
while others have dismissed such claims as premature.12,13 
Further research has advocated for a more differentiated 
use of the term.14-17 David Kirchhoffer argues in favor of the 
appropriate use of Human Dignity in ethical discourses as “the 
multidimensional existential reality of the human person.” 
This is an interesting approach, which seeks to avoid ‘dignity 
talk,’ ie, the unsolvable confronting reference to human 
dignity used as an argument by two parties of completely 
contrasting opinions.14 But also Kirchhoffer’s solution is not 
undisputed, as according to Matthews his view of “‘meaningful 
anthropology’ where a human person ‘adequately considered’ 
is ‘a conscious being who possesses the capacity to knowingly 
and willfully act’ seems to rule out all human beings who are 
not meaning-seekers or able to have desires of self-worth.”18 
Thus, especially for these excluded human beings, inherent 
dignity plays a pivotal role in the Human Dignity concept.18 
Notwithstanding these ethical debates, the Concept of Human 
Dignity has been embraced by international bodies, including 
the Council of Europe and the UN, and anchored in their 
international bioethical frameworks and conventions.19,20
Analyzing recent literature and policy events in more detail, 
it becomes evident that there has been some revival of the 
Concept of Human Dignity during the last decade.21-24 The 
Italian philosopher Corrado Viafora has pointed out that 
a – and potentially the – ‘locus anthropologicus’ of this 
millennium will lie in creating solid competencies in bioethics, 
including sound regulations on biomedical progress.25 As 
such, he introduced a methodology for the “ethical analysis 
of clinical practice based on the respect for human dignity,” 
in which he advocates for a stronger incorporation of human 
dignity in ethically driven clinical case management.26 We 
argue here that Viafora’s empirical, case based methodology is 
equally relevant and analogously applicable to public health. 
By applying this method to selected eminent public health case 
examples of the past 16 years, we wish to highlight the new 
role and informative potential of bioethics in German health 
policy and give a brief contextual outlook to the emerging 
field of PHE.8 Accordingly, this research article follows the 
appeal to broaden the bioethical scope27 by applying the case 
analysis method to German health policy. 
Viafora’s methodology for clinical case evaluation is based 
on principalism and the respect for Human Dignity 
(dignità umana), ie, pointing out the embeddedness and 
interdependency of the clinical situation in the Public Health 
context and state environment, including legal provisions26:
“In dealing with issues of commutative and distributive 
justice, clinical ethics extends beyond its specific competence 
and steps, respectively, into the field of politics and in the field 
of law.”26
The Concept of Human Dignity as integral part of the German 
Constitution warrants an effort of analogously applying 
Viafora’s methodology to the public health and prevention 
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case context in Germany. Human dignity is also increasingly 
considered important in a healthcare context.28 Viafora 
strongly believes in the “intrinsic value” of each human 
being, as reflected by the term human dignity. In reference 
to Gracia,29 he also considers as most crucial the ‘constructive 
process’ of verifying the respect for human dignity in a given 
case through experience.26
Viafora’s ethical methodology for clinical case evaluation can 
be comprehensively divided into three levels: 
The first level of “intrinsic value” is based on the recognition 
of human dignity, ie, the unconditional-respect-generating 
intrinsic value of each human being. Viafora considers this 
idea of Gracia as “the ultimate criterion for distinguishing 
– also in the biomedical field – among moral and immoral 
practices.”26
The second level of “constructive process” is based on the four 
biomedical ethics principles as formulated by Beauchamp 
and Childress30: autonomy, beneficence, non-maleficence and 
justice. These principles, for Gracia and Viafora, are the “first 
moral outlines of the respect for human dignity, ie, the first 
ways to actualize the respect for human dignity.”30 Thus, their 
formulation and – later in the third level - relation to concrete 
case-examples is required in order to verify the respect we 
owe to the intrinsic value of human dignity. This is what is 
referred to by Viafora as the “constructive process” on the 
second level. Unlike Gracia, Viafora only uses three principles 
at that stage (autonomy, beneficence, justice), as he argues 
that the principle of non-maleficence is already included in 
the Concept of Human Dignity.30 
The third level of “experience” consists of a “reflection phase,” 
ie, the necessity to “take into consideration the particular 
circumstances of the given case and the likely consequences 
of the different possible choices.” Subsequently, “experience,” 
on the third level “requires evaluating the outlined choice” 
with the particular circumstances of the given case and its 
likely consequences.26
It is common practice in bioethics to analyze individual clinical 
cases in terms of their ethical relevance and meaning, in order 
to give guidance for concrete patient treatment and the future 
development of a clinical field. However, these methods of 
individual case analysis have not yet reached broader use in 
the domain of public health. This research article, therefore, 
exhibits a health policy analysis that addresses exemplified 
German health prevention cases between 2000–2016. After 
reflection on Viafora’s human dignity and principalism 
(autonomy, beneficence, justice)-based method, a description 
of the German prevention policy structures and relevant case 
examples is performed, followed by an ethical evaluation that 
seeks to apply and adapt the Concept of Human Dignity to 
public health policy.26 
In summary, our particular focus is to adapt and transpose 
Viafora’s method on human dignity to the public health 
context, illustrate selected German prevention policy 
examples, and analyze them in terms of their ethical relevance 
to public health with a focus on human dignity. Finally, we will 
address, whether - and if yes, on what grounds - the ethical 
and human dignity-related implications of these German 
prevention policy cases could advance further development 
of PHE.
Methods
This research article exhibits a health policy analysis of German 
health prevention policy, analyzing the prevention structures 
and choosing eminent policy case-examples between the 
years 2000-2016, including a compendious ethical evaluation 
that seeks to apply and adapt the principalism (autonomy, 
beneficence, justice)-based Concept of Human Dignity of 
Italian philosopher Corrado Viafora, setting it into context 
with the emerging field of PHE.
Concretely, we here use a case based approach to evaluate 
public health policy on grounds of ethics and human dignity 
using the following methodology: 
(1)	 Adapt and transpose Viafora’s Concept of Human Dignity 
to the public health context, 
(2)	 Identify eminent examples of sustainable German health 
prevention policy from 2000 – 2016, 
(3)	 Analyze implications of these health policy examples 
from an ethical and human dignity perspective, and 
(4)	 Discuss the role of said implications in further 
development of PHE.
To further inform this health policy analysis, we have searched 
index databases (PubMed/MEDLINE, Google Scholar) and 
included relevant published and grey literature. The search 
was restricted to literature written in English and/or German. 
No formal restriction regarding the year of publication was 
made; however, emphasis was placed on including the most 
recent and updated information, whenever possible. 
Results
The Concept of Human Dignity in Public Health – A New 
Foundation of Public Health Ethics? 
There is ample evidence that after the millennium break 
German health policy made a considerate step towards 
prevention and health promotion, putting the strategies of 
‘personal empowerment’ and ‘settings based approach’ high 
on the federal government’s agenda; this phenomenon has 
significantly challenged the role of ethics in health policy.31-33 
The original German Social Law [Sozialgesetzgebung] by Otto 
von Bismarck, Chancellor of the German Reich in the 1880’s, 
had been based on three pillars, ie, ‘occupational health,’ 
‘acute care’ and ‘prevention’; however, initially human dignity 
had not been a ‘direct’ aim of social policy and legislation.34 
After being enshrined into the new German Constitution 
in 1949,35 the reference to ‘human dignity’ nowadays allows 
for a much more stringent application of prevention policy. 
However, it has taken quite a while for public health to get 
the attention of academic bioethics,3,36,37 resulting in the newly 
emerging field of PHE. PHE has barely been engaged with 
the notion and worth of human dignity and its potential 
usefulness to inform the foundation of ethical judgments 
in the public context. Despite this fact, human dignity has 
become increasingly interesting to healthcare professionals, 
lawyers, philosophers, bioethicists and politicians in general 
health debates.9 While mindful of the aforementioned partly 
critical ongoing debate,10,12,16 human dignity has gained 
profound importance for international legislation on human 
rights and biomedicine.19,20 This trend is also reflected by 
recent scientific literature as well as concrete policy events, 
suggesting a revival of the Concept of Human Dignity during 
the past years.21–24 
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The Concept of Human Dignity – From Clinical Practice to 
Public Health 
Based on our observation of these recent developments, 
Viafora’s “ethical analysis of clinical practice based on the 
respect for human dignity” as a bioethical concept could 
yield important insights when applied to examine bioethical 
conduct in a public health context. 
Viafora’s methodological principles are derived from 
Beauchamp and Childress “Principles of Biomedical Ethics” 
from 1979,30 ie, autonomy, beneficence, non-maleficence, 
and justice, which, in turn, are founded on a contextual set of 
societal degrees of freedom and consented norms of society: 
“Such principles are derived from considered judgments taken 
from common morality.”26
To Viafora, the Respect for Human Dignity is a necessary 
premise to any principle for ethical analysis. Thus, with the 
principle of non-maleficence inherent to human dignity, he 
holds the following of Beauchamp and Childress original 
principles sufficient to inform ethical analysis: 
(1) Autonomy (principle aiming at protecting and granting 
responsibility) 
(2) Beneficence (principle aiming at protecting integrity) 
(3) Justice (principle aiming at granting reciprocity) 
From his statement made in reference to Vetlesen38 that 
for ethical clinical case judgments “moral perception is a 
precondition of moral performance,”26 it can be analogously 
derived that specific preconditions of a state can serve to 
facilitate ethical conduct in a health policy context. Thus, 
in addition to Viafora’s three principles, we can identify the 
following four preconditions in the domain of public health: 
(I) A profound constitutional basis (based on human dignity) 
to enable ethico-legislative performance.
A reference to human dignity – as in the German Constitution 
from 1949 – has been incorporated into the 1997 Oviedo 
Convention of the Council of Europe39 and also into the 
Charter of Fundamental Rights of the EU in 2000,40 thereby 
establishing a common ethico-legal foundation for all 28 
societies of the EU Member States. According to Michael 
“(human) dignity matters, because it forms the foundation of 
civilized society.”41
As such, human dignity understood in a public health ethical 
context should have
(II) the potential to function as a common basis for 
justifying legislative endeavors through ethical judgments 
in our pluralistic society, ie, as a common good of societal 
understanding.
(III) a value that fosters cultural understanding to grant 
citizens a dignified life.
(IV) a guarantee to the unconditional worth of every human 
being.
As a systematic ethical framework, these three principles and 
four preconditions, summarized in Table 1, serve to analyze 
the potential of the Concept of Human Dignity in selected 
public health case-examples.
In approaching this endeavor, an understanding of the 
underlying political and cultural context that has shaped 
German health policy with regards to the topic of prevention 
and health promotion is necessary. 
From Cure to Prevention: A Paradigm Shift in German Health 
Policy – the 2015 German Preventive Healthcare Act 
Similar to the immediate impact a physician’s therapeutic 
decision can have on a patient’s life, health policy-making 
can profoundly impact a citizen’s personal freedom and 
well-being.42 On a European level, policy decisions of such 
scope, for example the concerted legal provisions to prevent 
and contain pandemic spread of recurrent communicable 
diseases, is coordinated by the so-called Chief Medical 
Officers Meeting of the EU Member States. Health Policy in 
Germany - as in all EU Member States - is embedded in a 
framework of democratic laws of civil and social as well as 
penalty nature, grounded on the principles of constitutional 
law. Article 1 in The German Constitution (Grundgesetz) 
states the following: “Die Würde des Menschen ist 
unantastbar [Human Dignity is inviolable].”35 Given the 
amount of executive power attributed to State’s public health 
authorities – in matters dealing with life and death –, it seems 
pivotal to have such a profound basis for the democratic and 
legal framework of a country.41
The societal debates about a liberal or a more rigorous 
approach in order to reach common preventive goals can be 
full of tension, the reason for this dilemma is described by 
Hans-Martin Sass in the following phrase:
“If health risks are present or predictable, a right to know 
and an obligation to tell exist. A moral not a legal obligation 
to follow healthcare advice applies, however; and it becomes 
more pressing if healthcare costs are shared in solidarity.”43
Decreasing birth rates and younger retirement ages in 
Germany fostered the notion that a policy shift towards 
prevention was essential to stabilize the German social 
system, helping to prevent the outbreak of disease, ensure 
early diagnosis and facilitate improved coping strategies.33 
Prevention was also increasingly seen to have the potential 
of preventing or delaying early retirement and nursing care, 
Table 1. Summary of the Concept of Human Dignity
Principles
1st Principle
2nd Principle
3rd Principle
Autonomy 
Beneficence
Justice
→ Principle aiming at protecting and granting responsibility
→ Principle aiming at protecting integrity
→ Principle aiming at granting reciprocity
Preconditions, as Based on Human Dignity 
Precondition I
Precondition II
Precondition III
Precondition IV
Profound constitutional basis
Common good of societal understanding
Dignified life
Unconditional worth
→ Enable ethico-legislative performance
→ Common basis justifying legislation by ethical judgments in pluralistic societies
→ A value fostering cultural understanding for granting humane circumstances to everybody
→ Guaranteeing the unconditional worth for every human being in society
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with specific emphasis on fostering patient participation 
in disease management, eg, in the sense of the recently 
established concept of empowering patients as “co-producers 
of care.”44,45 Therefore, German health policy had initiated 
the German Forum on Prevention and Health Promotion 
(being a voluntary, although Ministry-driven, joint venture 
of relevant actors in prevention) in 2002 and worked on 
preparations for a Law on Prevention.33 In addition, the 
Health Ministry supported initiative of “health targets 
in Germany” [“gesundheitsziele.de”], coordinated by the 
Society for Insurance Sciences & Creation [Gesellschaft für 
Versicherungswissenschaft und Gestaltung, GVG], evolved 
during the last decade, defining common goals and targets in 
health, quality standards, inter alia the aim of non-smoking.46 
However, this paradigmatic shift from cure to prevention 
has taken many years of political and parliamentarian 
debate, culminating in the recent enactment of the German 
Prevention Law in July 2015.47 The Act to Strengthen Health 
Promotion and Preventive Healthcare (Preventive Healthcare 
Act) came to force on July 25, 2015, with the leading goal 
of prevention of disease before its manifestation.47 The 
Act seeks to strengthen health promotion through a direct 
settings-based approach, ie, intervening locally in nursery 
schools, primary and secondary schools, in the workplace 
and in nursing homes. In addition, implementation of 
screening tests for children, young people and adults will 
be reinforced and vaccination coverage fostered. A targeted 
cooperation between all key players in prevention and health 
promotion is foreseen, especially between statutory health, 
statutory pension, statutory accident, statutory long-term-
care insurance as well as private health insurance. Through a 
National Prevention Conference, where participants include 
the social security institutions, the Federal Government, 
the Laender, the local authorities, the Federal Employment 
Agency and the social partners, mutual prevention and health 
promotion goals will be identified to develop a joint strategy.47 
Generally, in Europe, there is a tendency of national health 
policies to approach Public Health issues through capacity 
building.48
A major burden of disease in Germany stems from so-called 
ambulatory care sensitive conditions (ACSCs), ie, chronic, 
lifestyle-associated diseases such as diabetes mellitus, 
chronic obstructive pulmonary disease, hypertension and 
cardiovascular disease that require continuous ambulatory 
therapeutic guidance as well as active disease self-management 
by patients.49,50 WHO estimates that through timely and 
effective provision of ambulatory care approximately 75% 
of hospitalizations for ACSCs are actually preventable, eg, 
corresponding to a fifth of all hospitalizations in Germany 
in the year 2012.50 While the WHO identifies a clear need to 
restructure ambulatory services towards more integrated care 
in Germany, it also highlights the role of secondary and tertiary 
prevention as key measures to ensure long-term functional 
ability of patients with chronic disease. One example – 
foreseen by the 2015 enacted German E-Health Law – is the 
implementation of a comprehensive IT infrastructure across 
levels of care, with patient access to their own E-Health data 
to “foster patient autonomy and stimulate patients’ health 
literacy, self-care and better adherence to treatment.”50
Whereas the old system had chiefly focused on therapy 
and nursing, the new political institutionalized strategy of 
prevention – including primary, secondary and tertiary 
prevention – granted the opportunity of a stronger public 
debate on financial issues of sustainable Public Health 
development. Clearly, there is a right for all citizens to benefit 
from scientific progress in genetics and healthcare51– a right, 
which should also be warranted for the public health sector. 
While the idea of a health system being merely a “repairing-
system” is increasingly politically and publicly questioned, 
options for a more holistic, ie, preventive approach that 
would incorporate aspects of ethical and social justice, are 
more and more considered.23,52 Furthermore, since about 
10 years, a clear trend towards a development of evidence-
based prevention (EBP) can be observed.53 This development 
of a stronger focus on evidence in prevention coincides with 
the emerging era of PHE in Germany, that has recently also 
shaped the international debate in a broader context.36,54 
Concurrently, within the last 5 years PHE discourses in 
Germany have intensified.55
Eminent Examples of Sustainable German Health Prevention 
Policy From 2000-2016 
Leading up to the 2015 Preventive Healthcare Act, five eminent 
German health prevention policy cases that preceded/
accompanied the Act were identified for subsequent ethical 
analysis. These examples were chosen from different fields of 
prevention based on their specific eminent political and social 
relevance as well as on grounds of their distinct nature from 
one another. The chosen cases are summarized in Table 2.
Case-Example 1 – Preparedness Against Pandemic Influenza
Three pandemic outbreaks of influenza occurred during the last 
century (in 1918, 1957, and 1968). Those that occurred during 
the second half of the century took place in the era of modern 
virology and thus have been virologically characterized.56 All 
three have been identified by their presumed sites of origin, ie, 
as Spanish, Asian, and Hong Kong influenza, now known to 
represent 3 different antigenic subtypes of influenza A virus: 
H1N1, H2N2, and H3N2, respectively. Influenza management 
is hindered by unpredictability of outbreaks and huge variety 
Table 2. Eminent Examples of Sustainable German Health Prevention Policy From 2000-2016a
Case 1 State’s Preparedness against Pandemic Influenza 2006-2016
Case 2 HPV- Vaccination Program against Cervical Cancer 2007-2016
Case 3 Legal Provisions on Non-smokers Protection 2005-2016
Case 4 Acts to Strengthen Long Term Care 2013; 2016
Case 5 The New German E-Health Legislation 2015; 2016
a Five eminent examples of sustainable German health prevention policy and their respective implementation timeframes are displayed. The examples were 
chosen from the period of 2000-2016, ie, preceding/accompanying the 2015 German Preventive Healthcare Act.
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of de novo forming subtypes. Evidently, true pandemics arise 
from genetic reassortment with animal influenza A viruses.56
In 2006, a new global public health threat appeared to arise in 
terms of pandemics, the so-called avian flu. Miller et al have 
described the urgent necessity of intense and transnationally 
coordinated preparation of public health systems to combat 
the pandemic threat, stating that “the evidence of multiple 
waves in the 20th-century pandemics underlines the 
importance of active real-time viral surveillance on a global 
scale.”57 Consequently, transnational collaborations are 
considered crucial to effective exchange of genomic, clinical, 
and epidemiologic data leading to the development of vaccines 
and treatment protocols and the identification of population-
based strategies.57 What is striking - and has mainly been 
known by a select few experts in the epidemiological field - is 
that a timely preventive preparation of healthcare systems can 
be effective in saving dozens of thousands of lives. Avoiding 
this “hidden death threat” is first and foremost a task of 
establishing a sustainable health prevention policy that cares 
for its citizens on a population basis and on grounds of human 
dignity, ie, aiming at protecting the life of each individual 
citizen.
Apart from effective preparations for scaling up and 
implementing immunization strategies as early as possible, 
additional general public health measures, like obedience 
of hygiene protocols and certain quarantine provisions, are 
proven feasible strategies to reduce the course and spread 
of pandemic disease. One of the globally most discussed 
additional measures of precaution is the stockpiling of 
anti-viral agents and secondary antibiotics. Especially the 
precautious necessity of stockpiling of anti-viral agents had 
been the focus of Germany’s public debates. Accordingly, 
ethical issues and challenges associated with the pandemic 
threat had been considered, too. Specifically, from a political 
perspective, it became increasingly important to address 
ethical implications of pandemic influenza preparedness and 
to take ethical reasoning into account when making political 
decisions pertinent to the management of pandemics.37 As 
huge allocation decisions were to be made by politicians on 
State levels, the matter of social justice and proportionality 
had to be closely examined and carefully balanced against 
potential “losses” in terms of population disease burden and 
estimated casualties.
Case-Example 2 - HPV-Vaccination Program against Cervical 
Cancer
At the beginning of the new millennium, the former director 
of the German Cancer Research Center (DKFZ), Harald zur 
Hausen, suggested to use the results of human papilloma virus 
(HPV) research that had identified the oncogenic potential 
of HPV, to develop vaccines and a subsequent strategy for 
systematic vaccinations against cervical cancer58:
“An important practical impact originates from the 
development of prophylactic and therapeutic vaccines. 
Theoretically, cervical cancer, which contributes to 
approximately 12% of the global cancer burden in women, 
should be preventable.”58
These strategies led to the development of the first cancer 
vaccine and to a nationwide prevention program for 
vaccination against cervical cancer in Germany and other 
countries. Highlighting the extraordinary scientific, medical, 
and social impact of his work, Zur Hausen received the 
Nobel Prize in 2008 for “his discovery of HPVs causing 
cervical cancer.”59 A high impact on public health by the 
broad introduction of this cancer vaccination is foreseen. As 
more than 20% of the global cancer burden is estimated to 
be linked to infectious agents,60 other vaccines against many 
different infection-associated forms of cancer will likely be 
developed in the future. Moreover, rapid advances in cancer 
immunotherapy research support the notion that vaccine-
induced immune cell reprogramming, such as via targeted 
delivery of RNA-encoded cancer antigens to dendritic immune 
cells,61 may soon become an important therapeutic pillar with 
potentially universal application in cancer treatment. 
The vaccination program against cervical cancer started 
in March 2007, Germany being among the first European 
countries to implement this important step for public health 
and cancer prevention.62 HPV vaccination for the prevention 
of cervical cancer has since been recommended in most 
countries of Western Europe. Varying conditions among 
healthcare systems and nationwide data in the individual 
European countries lead to slightly different cervical cancer 
prevention strategies. However, there is overall consensus to 
monitor the public health impact of HPV vaccines.62 
Public debates about the implementation of anti-cancer 
vaccines have addressed the safety and efficacy of the 
vaccines as well as questions regarding the optimal target 
group, including gender aspects. In terms of monitoring 
the vaccination program, a consistent epidemiologic survey 
about the acceptance and the factual immunologic status of 
the population is essential.63 Interestingly enough, there is a 
high demand for additional vaccination campaigns, in order 
to increase the acceptance and vaccination status also in girls 
with lower education backgrounds.63 
Generally, in order to overcome a certain monitoring deficit, 
an health technology assessment (HTA)-report on cervical 
cancer has recommended the implementation of an organized 
screening program for quality-controlled introduction of 
HPV-screening and -vaccination with continued systematic 
outcome evaluation.64
Case-Example 3 - Legal Provisions on Non-Smokers Protection
Consumption of tobacco is a risk factor for six out of eight 
major causes for death; in industrial nations, it is the most 
important health risk and considered to be the leading cause 
of early death.65 
Despite these overwhelming epidemiological facts it has taken 
a considerate amount of time, until the Federal Republic 
of Germany took sufficient initiative to combat tobacco 
consumption in a sustainable manner. In part, this has been 
a matter of constitutional structure – the 16 Federal States of 
Germany each bearing individual legislative responsibility 
for Health Protection [Gesundheitsschutz] on a Laender 
level– such that there was a discussion about legislative 
competencies concerning potential legal provisions on non-
smokers protection. Mons and Pötschke-Langer note the 
following:
“Structural measures of tobacco prevention are effective and 
cost-efficient measures to reduce tobacco consumption and 
the related health and economic consequences. However, 
Winter and Winter
International Journal of Health Policy and Management, 2018, 7(3), 210–224216
Germany has been very reluctant in implementing tobacco 
control laws for several decades. Only recently has Germany 
increased its efforts in tobacco control, which has resulted 
in a decrease of tobacco consumption and in a decrease of 
smoking rates, especially in youths.... For decades, politics 
gave in to pressure and influence of lobbyists of the strong 
tobacco industry, which deceived the public and politics for 
their economic interests and in order to establish a high social 
acceptance of smoking. In addition, there is the phenomenon 
of ‘denialism,’ which means the convinced denial of scientific 
findings regarding smoking and smoking prevention in 
opponents of tobacco control, who are not directly affiliated 
with the tobacco industry.”66 
There are certainly also other historical aspects to name 
in the German context. Due to the State imposed ideas of 
“Volksgesundheit” and their misuse during the dictatorship 
from 1933-1945, the Public Health development in Germany 
had almost been completely discredited in the second half of 
the last century and left the Germans (quite understandably) 
with a vague feeling of uneasiness towards all sorts of Public 
Health measures that would entail any kind of coercion.67 This 
historical predisposition, in fact, harbored an easy ground for 
the cited phenomenon of “denialism,”68 which has been and 
is still playing a significant role the debate of non-smokers 
protection. 
Evidently, denialism has widely dominated this political 
debate; however, the first publicly convincing argument, 
which could not so easily be swept away by “liberal” deniers, 
was a thorough statistical meta-analysis concluding that a 
concrete figure of n = 3301 deaths per year in Germany were 
caused by passive smoking alone.69 The fact that almost 10 
innocent persons die day-to-day in Germany as a consequence 
of passive smoking introduced a “public moral awareness” of 
the former merely ‘hidden’ statistics on smoking and health 
threats. Although produced by a complicated statistical 
analysis, the opportunity to imagine and being able to relate a 
concrete number of persons dying for non-self-caused reasons 
(eg, the threat to the pregnant waitress in a smokers bar, who 
has to earn money for herself and her future child, and is 
thus financially tied to continue working in a high health risk 
setting), did not only help steer the German political debate 
towards a more preventive health protection policy in the 
field of passive smoking. Critically, it also evoked a judicial 
constitutional court decision on anti-smoking legislation, 
namely the dissenting vote of German Constitutional Judge 
Masing. In its justification, the vote clearly indicated the legal 
option for the State to prohibit smoking in public areas.70 
This ruling thus granted policy-makers and the legislator to 
include the argument for third party protection in further 
anti-smoking legislation.
“However, the prevention of addiction is a legitimate goal 
of the legislator, who can allow for impeding, limiting or 
reducing partly from the public perception those liberally 
granted habits, that have at the same time the potential 
for addiction. The legislator can, in so far, in view to 
negative consequences for third parties or the public or 
also immediately for reduction of addiction, release legal 
provisions for the protection of temptations of those affected 
and thus for themselves” (translation by authors).70
It would exceed the scope of this research article to outline 
the various attempts of the 16 States of Germany to achieve 
a suitable regulation on non-smokers protection. It can, 
however, be exemplified with the case of the State of Bavaria, 
which after initially choosing a relatively loose legal provision 
for protection of non-smokers in public places in 2007, 
had to revise its legislation following a public opinion poll 
in 2010 that showed a 61% public support vote for a more 
rigorous anti-smoking policy, thus leading to a strict anti-
smoking law in all public places with almost no exceptions.71 
Kohler and Minkner recently summarized the complex 
situational interplay between anti-smoking legislation and 
direct democracy initiatives on smoking bans in Germany, 
exhibiting that the federal government structure and direct 
democratic participation in anti-smoking legislation in 
Germany has produced a diversity of local smoking bans and 
exemptions.72 
Case Example 4 – Strengthening Long Term Care in Germany 
In response to the rapidly aging German society and 
concurrently increasing prevalence of the long term care 
(LTC) services dependent multimorbid patient population 
in Germany,7 the 2013 LTC Realignment Act [Pflege- 
Neuausrichtungsgesetz] brought a preventative angle into 
German LTC provision, specifically by fostering the 2008 
“rehabilitation before care principle” and by strengthening 
ambulatory LTC services through establishing novel forms 
of residential care provision [Pflege-WGs].73 Notably, care 
benefits for dementia patients were introduced through a 
fundamental redefinition of the “need-for-care principle” 
[Pflegebedürftigkeitsbegriff] that now recognizes dementia 
as a mental disability warranting long-term care.74 Other 
measures included increasing the support for informal care 
providers, boosting flexibility of LTC services and benefits 
provided, and fostering intersectoral coordination between 
different LTC providers.73 
The LTC Realignment Act laid the foundation of the 
subsequent 2015 LTC Strengthening Acts. While the First Act 
to Strengthen LTC [Erstes Pflegestar̈kungsgesetz] increased 
LTC insurance (LTCI) benefits by 4% and boosted benefits 
and services for LTC at home,75 measures of the Second 
Act to Strengthen LTC [Zweites Pflegestar̈kungsgesetz] are 
implemented implemented by 2017 and focus on supporting 
patient self-reliance, henceforth determining levels of care-
dependency chiefly through assessment of patient self-
reliance restrictions.76,77 Cumulatively, the proposed budget 
for LTC will increase by almost €5 billion by 2017, thus 
boosting overall benefits of LTCI services by 20%.75 
Case Example 5 – The New German E-Health Legislation
 Whereas the medical and economic potential of telemedicine 
and E-Health for public health is enormous (a fact, mutually 
agreed upon by the majority of stakeholders), a practical gap 
towards health system-wide implementation of the necessary 
steps to reach the full range of the benefit for patients and 
healthcare professionals still exists. Thus, in Germany it 
has taken a relatively long period of time to gather all key 
players of the national healthcare system to pave the way 
for a concerted action towards a joint German telematics 
infrastructure (TI). Based on German Social Law, in 2004 a 
competent national authority, gematik GmbH, was established 
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by the Federal Government, in which doctors, dentists, 
pharmacists, hospitals on one hand (care providers) and the 
federal organization of statutory health insurances on the 
other hand (payers) govern the TI-implementation process 
in a joint effort. They have made considerable progress in 
their common aim to build a TI (especially throughout 
the last three years) led by the following reasoning on the 
future benefits of the electronic health card (eHC). The full 
implementation of the eHC amongst all statutory insured 
citizens is considered the first milestone to Germany’s TI. As 
such, doctors, dentists, pharmacists, hospitals, 113 statutory 
health insurance companies and 70 million publicly insured 
will potentially be able to benefit from a well-integrated 
and established TI. The following specified goals highlight 
this process: improvement of the quality, transparency and 
efficiency of treatment through an electronically networked 
healthcare system; assurance that the rights and data of 
patients are protected within a connected healthcare system; 
simplification of the information and data exchange between 
all parties involved, ie, overall shorter, faster and safer ways 
to communicate amongst different participants within the 
treatment process; less bureaucracy and administrative 
burden for benefactors and care providers.78
On January 1, 2016, the Act on secure digital communication 
and applications in the healthcare system (E-Health Act) was 
enacted in Germany.79,80 It focuses on secure digital networking, 
which can save lives and fosters patient empowerment. The 
E-Health Act provides the essential basis for qualitative 
improvements in terms of prevention. Together with the 
Federal Commissioner for Data Protection and the Federal 
Office for Information Security (BSI), a system providing 
the best possible protection for highly sensitive patient data 
was established and will be implemented by doctors, dentists, 
hospitals, pharmacists, insured patients, statutory insurances 
and industry within a foreseeable timeframe. Key figures of 
the E-Health Act include a modern core data management 
for the insured, medical emergency data and medication 
plan on eHC, drug interaction safety, digitalized patient 
discharge letters, electronic patient records, wider use of 
telemedicine and further fostering of interoperability. Once 
in full function, the Act will provide an eminent preventive 
structural framework for the healthcare system, serving to 
avoid medical errors while ensuring quality of care in the 
broadest approach possible.
German Health Prevention Policy Analysis From an Ethics 
and Human Dignity Perspective
During the last decade, German health policy has, as shown 
above, experienced a considerable policy shift combined with 
structural changes that have resulted in the institutionalization 
of health prevention on both Federal and State levels. This is an 
important step to protect and grant autonomy/responsibility 
for eminent questions concerning population health needs. 
The observed process equally pursues the principle of 
beneficence, aiming at the individual’s integrity, since efforts 
of these concerted policy frameworks are respecting exactly 
this aim. This is also shown by the agenda of the platform 
“health targets in Germany” [gesundheitsziele.de].46 Likewise, 
the principle of justice and reciprocity is achieved, as nothing 
for a population of a State is as important as having the State 
take the preventive health needs of its population and its 
health protection as serious as possible.33 In fact, the profound 
constitutional basis in terms of respect of Human Dignity 
is given for all ethico-legislative processes by the German 
Constitution.35 Thus, in the German society the value of 
Human Dignity can function as a common good of societal 
understanding. The new German framework for fostering 
prevention is explicitly designed to support the citizens of 
Germany in their thrive for leading a dignified life concerning 
their health and seeks to protect them from avoidable health 
threats. Finally, the unconditional worth of each individual 
citizen is respected in the political prevention framework. 
Finding the principles and preconditions of the Concept 
of Human Dignity recurrently implemented in the recent 
evolutionary process of preventative healthcare structure 
establishment in German health policy, has prompted us to 
apply this concept onto each of the five eminent prevention 
policy examples, compendiously analyzing and evaluating 
them on grounds of human dignity (see Table 3). 
The compendious ethical analysis (Table 3) illustrates the 
immanent representation of human dignity driven ethical 
principles displayed in all five analyzed cases. 
Whereas in Case 1 (State’s Preparedness against Pandemic 
Influenza) we can observe a pertinent representation of 
and compliance with all principles and preconditions, 
the remainder of analyzed cases – while overall showing 
substantial incorporation of human dignity based ethical 
content – reveal different degrees of insufficient fulfillment 
of the Concept of Human Dignity. As such, Case 2 (HPV-
Vaccination Program against Cervical Cancer), Case 3 (Legal 
Provisions on Non-Smokers Protection) and Case 4 (Acts for 
Strengthening LTC) contain deficits regarding the principle 
of justice, since their respective policies are partially prone 
to disadvantage subgroups of the population in Germany 
(see Table 3 → Justice Principle). Whereas a constitutional 
basis (precondition I) is anchored in these policies, the 
observed disadvantage is also reflected in the merely partial 
fulfillment of preconditions II-IV, as both the dignified 
life and unconditional worth aspects are not safeguarded 
for those subgroups, nor is a common good of societal 
understanding fully accomplished. In addition, the huge 
societal cost associated with both smoking-associated health 
expenditure and LTC-provision (Cases 3 and 4), respectively, 
challenge solidarity thereby hampering the common good of 
societal understanding, touching upon aspects of the justice 
principle.88 
For the still ongoing policy implementations of Case 5 (The 
New German E-Health Legislation) we observe a generally 
good compliance with all three principles, however, noting 
a foreseeable risk of exclusion, and thus potential future 
disadvantages, of certain age- and education-groups for 
novel extended telematic applications (eg, in patient self-
management)89 and data protection issues.90 For the Human 
Dignity-based preconditions, a potentially reduced fulfillment 
of the dignified life precondition (III) for said age groups as 
well as a still insufficient societal consensus (II) on- and slow 
process of policy implementation (potential ethical type-2 
error/omission bias → jeopardizing the unconditional worth 
precondition (IV)) suggest room for improvement. 
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Table 3. Compendious Ethical Analysis of German Health Prevention Policy From a Human Dignity Perspective
State’s Preparedness 
against Pandemic Influenza
2006-2016
Preparedness against 
pandemic influenza, as 
provided by the State’s 
governments and Public 
Health authorities, implies 
complex and profound 
health prevention 
interventions, especially 
extensive logistic planning, 
including the safeguarding 
of public life and economy.81
Principles
1. Autonomy 2. Beneficence 3. Justice
+ Pandemic preparedness planning avoids reduction of citizens to passive 
subjects “awaiting disease.” 
+  Safeguarded by adequate 
preventative measures. 
+  Concurrent protection of personal 
integrity. 
+ Fulfilled as prevention policy seeks to protect the maximum / ideally the entire 
population. This was the case in the influenza preparedness plan of the Federal 
Government.82
Preconditions
I Profound constitutional basis II Common good of soc. understanding III Dignified life IV Unconditional worth
+ Taking the protection of individual Human 
Dignity (Article 1 of the German Constitution) as a 
guideline, Public Health stakeholders should ensure 
population-wide allocation of vaccinations.
+ On the State level, resource allocation for 
influenza preparedness was importantly 
influenced by a mutual perception that a non-
interventional / passive attitude would be 
highly unethical.
+ Leading a dignified life in terms of 
health for the individual is only possible, 
if States and the Federal Government use 
all available knowledge and resources 
to guarantee a maximum degree of 
preparedness.
+ Only with 100% population coverage and using all 
available preventive measures, a State can demonstrate and 
guarantee that the unconditional worth of each individual 
citizen is fully respected.
HPV-Vaccination Program 
against Cervical Cancer
2007-2016 
Until the last decade, 
a vaccination against 
development of cancer 
had been an utopian 
imagination.58 Launching 
the first ever cancer vaccine 
(Gardasil®) in September 
2006 changed that 
situation drastically. Shortly 
thereafter, German Public 
Health officials publicly 
recommended a broad 
vaccination program for 
teenage girls, announced in 
spring 2007.62
Principles
1. Autonomy 2. Beneficence 3. Justice
+  Fulfilled by recommendation and offering of vaccinations on a voluntary 
basis.
+ Inclusion of vaccination service for target groups in SHI and PHI. 
+ Fulfilled due to good evidence for 
efficacy of vaccination in preventing the 
later development of cervical cancer.62
+ Offered to all eligible teenage girls without exception. 
- Concerns of including also 1) girls with prior sexual activity and 2) teenage boys as 
additional groups with potential anti-cancer protection.62
Preconditions
I Profound constitutional basis II Common good of soc. understanding III Dignified life IV Unconditional worth
+ The constitutional basis for protection of Human 
Dignity is given in the German context.
- This might be a point for reconsidering 
the strategy currently chosen, because the 
implementation figures of vaccination in low-
education-populations are only half of those in 
high-educated milieus.63
-  If Human Dignity is perceived as a common 
good of societal understanding as it should, 
we could question the degree of social 
inequality in terms of gender needs as well as 
concerning a lack of appropriate educational-
level-adapted vaccination strategies.
+  Concerning the aspect of leading 
a dignified life, clearly the aim of the 
program contributes to that idea in 
avoiding a potentially deadly disease.
- However, this is only done for a part of 
the relevant population.
- As only a part of the population is covered, the respect for 
the unconditional worth of every human being is only partly 
met by the program.
- What in general, seems to have to be addressed (however 
early the experiences with this new program are) is a 
more sustainable implementation effort of the vaccine 
program and the creation of a more sufficient epidemiologic 
database.64 
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Legal Provisions on Non-
Smokers Protection
2005-2016
There is hardly a field 
more disputed in societies, 
especially in the German 
public, as the debate on 
legal provisions on non-
smokers protection.69 
Therefore it seems all 
the more astounding 
that – despite these 
heavy debates – finally a 
stronger political and even 
plebiscitary momentum 
has led (at least in some 
States of Germany, eg, 
Bavaria) to clear preventive 
and health protective legal 
provisions.71,72
Principles
1. Autonomy 2. Beneficence 3. Justice
+  Fulfilled as State has taken responsibility to protect non-smokers (potential 
passive smokers) who simply did not have that ‘autonomy’ before in public 
places, ie, as they could not opt-out of the passive smoking situation.
- 1/3 of German annual healthcare expenditure (97 billion €) is spent to cover 
direct and indirect costs of smoking.83
+ Fulfilled by protection of potential 
harm from passive smoking in public 
spaces.
- Not fulfilled for forced passive 
smokers, eg, children, in private 
households.
+ Fulfilled as prohibiting smoking in public places ensures the protection of health 
as a human right.
+ Smokers feeling “unjustly” treated as a result of this enactment, should be 
aware that, whereas smoking is a deliberate lifestyle choice, individual health is a 
fundamental human right necessitating protection at all times. 
- With respect to the cost of smoking (see autonomy) justice is not given for 
statutory health insurance, due to lack of risk premium differentiation between 
smokers and non-smokers.  
Preconditions
I Profound constitutional basis II Common good of soc. understanding III Dignified life IV Unconditional worth
+ A Constitutional Judge’s dissenting opinion, 
grounded on the German Constitution, initiated 
the State’s third-party protection measures for 
passive smoking prevention.70
+  Smoking Community’s gradually increasing 
awareness and understanding towards 
respecting the needs of non-smokers and 
vulnerable groups (children, elderly, the 
chronically ill).84 
+ Even smokers increasingly understand 
the prohibitive regulations as a “dignity 
protecting consequence” of the new 
legislations.
- A passively smoking child in a private 
household is still not leading a dignified 
life, as the legislations only apply to 
public spaces.
+ Acceptance of smoking as harmful to one’s own health, 
thus appreciation of one’s personal unconditional worth. 
- The unconditional worth of passive smokers (often 
children) in private households is neglected. 
Acts for Strengthening Long 
Term Care 
2013; 2016
In response to the rapidly 
aging German society and 
concurrently increasing 
prevalence of the LTC 
(LTC) services dependent 
multimorbid patient 
population in Germany,7 
the 2013 LTC Realignment 
Act as well as First and 
Second Acts to Strengthen 
LTC 2015- 2017 (expected) 
were launched.73 Through 
a more patient-centered 
approach, these Acts 
induced a fundamental 
redefinition of the “need-
for-care principle”74 as well 
as a focus on determining 
levels of care-dependency 
chiefly through assessment 
of patient self-reliance 
restrictions.76,77
Principles
1. Autonomy 2. Beneficence 3. Justice
+ As patients in need for LTC can genuinely be involved with losses of degrees 
of freedom and self-determination, the proposed social and fiscal concept of 
LTC is supporting the principle of autonomy.
+ State's recognition of dementia as a 
mental disability warranting long-term 
care and consequent redefinition of the 
“need-for-care principle” in the 1st and 
2nd Act to Strengthen LTC as a means 
to adapt to our rapidly ageing society is 
pursuing the principle of beneficence, 
for an ever-growing group of individuals 
in need for care.
+ Warrants a more equitable access to LTC for patients with mental illness.
- Concern regarding gender inequality, as the large majority of informal caregivers 
are women.73
- Risk of cultivating income-related inequalities of care provision, since a part of 
care-giving is intended to be paid for privately and/or is provided by families.50,85
Preconditions
I Profound constitutional basis II Common good of soc. understanding III Dignified life IV Unconditional worth
+ For the novel German LTC-Legislation, the 
Constitutional basis guaranteeing Human Dignity is 
an important precondition.
- Several concerns (see: Justice Principle) related 
to income inequality aspects50,85 and gender 
inequality.73
+ The need for access to care has developed 
to a kind of common good of societal 
understanding.
 - The ultimate goal of fair access and 
distribution of LTC has not yet been reached 
(see: Justice Principle).
- Societal understanding of extent of 
necessary LTC measures is hampered by huge 
associated societal cost.
+ The intention and directions of the 
novel LTC legislation aim at the goal 
of leading a dignified life, now also 
including sufferers of mental disorders.
- Still huge individual burden of cost for 
LTC-dependent citizens and individual 
fiscal inequalities.
- Further social and fiscal justice by 
additional legislation is needed to 
ensure a more dignified life for informal 
caregivers (mostly women).
+ The redefinition of the “need for care” principle, and with 
it the inclusion of dementia as a mental disability warranting 
LTC provision, is an important step towards realizing the 
preconditions for the unconditional worth of every human 
being.
- Full potential not yet reached (see previously mentioned 
concerns; Justice Principle). 
Table 3. Continued
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The New German E-Health 
Legislation
2015; 2016 
On January 1, 2016 the 
Act on secure digital 
communication and 
applications in the 
healthcare system (E-Health 
Act) was enforced in 
Germany.79,80 It focuses on 
secure digital networking, 
which can save lives and 
helps to empower patients. 
The E-Health Act provides 
the essential basis for 
qualitative improvements in 
terms of prevention.
Principles
1. Autonomy 2. Beneficence 3. Justice
+ Telematics and new tools of E-Health have the potential to empower 
patients in their ability of health literacy and self-determination. 
+ Informed individual decision making of patients across the care trajectory is 
a core feature of medical information technologies.
- Risk for exclusion of certain age groups, ie, foreseeable lack of “tech know-
how” and associated health literacy problems with elderly people.
- Potential risk of data protection issues.
+ Quality assurance aspects, such as 
avoiding redundant examinations or 
preventing misinformation of doctors 
about a patient’s condition, are 
undoubtedly excellent benefits for a 
patient.
+ Unnecessary treatment, eg, due to 
possible lack of sufficient information, 
will be avoided in an established 
functioning telematics infrastructure 
environment.
+ Medical information technologies within a telematics infrastructure will be 
available for all insured, granting fair access to all necessary health information to 
both patients and care givers in every relevant health context.
Preconditions
I Profound constitutional basis II Common good of soc. understanding III Dignified life IV Unconditional worth
+ Novel scientific developments for health 
treatment improvements with increasing 
opportunities for medical information technology 
applications oblige the State - on grounds of its 
constitutional basis of Human Dignity- to guarantee 
and safeguard the framework for a sound 
telematics infrastructure provided by the new 
E-Health Act.86
+ After one and a half decades the political 
debate on the Federal level has resulted in 
a common good of societal understanding, 
which finally lead to the implementation of a 
legal provision for E-Health.
- However, the law reflects only a minimum 
consensus, due to reservations of many 
healthcare stakeholders against several 
E-Health applications. 
+ Healthcare quality improvement with 
electronic tools that provide appropriate 
information for insured and care givers 
and thereby avoid medical errors adds 
to ensuring a more dignified life for 
patients. 
 - With the continual extension of 
telematics, health literacy problems due 
to age or education status might hamper 
the approach (see: Autonomy principle).
+ The participatory aspect of the telematics infrastructure, 
ie, the- in principle - just and fair distribution and 
accessibility for everyone, would respect the unconditional 
worth of every citizen.
 - The slow process of implementation delays the expectable 
societal, patient, and provider benefits (ethical type-2 error/ 
omission bias).87
Abbreviations: LTC, Long Term Care; PHI, private health insurance; SHI, statutory health insurance; soc. = societal
Note: Five eminent examples of sustainable German health prevention policy from 2000-2016 are analyzed and evaluated based on the three principles and four preconditions identified in the Concept of Human Dignity. Favorable, ethically 
aligned aspects (+) as well as potential points warranting improvement from an ethical perspective (-) of each policy example are displayed. 
Table 3. Continued
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Role Human Dignity in Further Development of Public 
Health Ethics: A Future Perspective 
The 21st century for many healthcare systems has coincided 
with a stronger focus on prevention and health promotion by 
governments, patients and providers.7,91 Another important 
new development is the concentration on “patients’ rights.” 
In Germany, a patients’ rights law has recently been 
established,92 and since 2004 an ombudsman for patients’ 
rights has been appointed by the Federal government.93 All 
these developments point into the right direction, however, as 
Cohen and Ezer94 have stated: “As patients’ rights movements 
and charters grow in popularity, it is important to link patient 
rights back to human rights standards and processes that are 
grounded in international law and consensus.” Human rights 
standards as such provide the basis for modern states and 
“(human) dignity matters, because it forms the foundation of 
civilized society.”41 One of the pivotal points of human rights 
is the Concept of Human Dignity, a concept, which has been 
well established in ethical reflection of novel technologies, 
such as genetics, during the last two decades.95 
The gradual impact of evidence-based prevention and 
health promotion tools on health policy legislation will be 
comparable to the ongoing influence of novel scientific 
breakthroughs in genetics or information technologies.51,96 
Therefore, it seems only a matter of consistency that the 
human rights aspect, which thus far has been attributed 
mainly to novel technologies,19,20 will be extended towards the 
vast evolving field of Public Health.97 The ethics of clinical 
patient care involves compassion98; the same should apply for 
health policy ethics, taking human dignity into account in its 
decision making process. Thus, in parallel to this movement 
of compassion in healthcare, the current development of PHE 
as a separate scientific field, in conjunction with the growing 
sector of Public Health Law, will enable a new fruitful debate 
on the importance of the Concept of Human Dignity as a key 
component of human rights in public health policy.
Conclusion
Whereas the 1990ies in Germany were still marked by a 
large political and public bioethical debate on new medical 
technologies – chiefly in the domains of biomedical research, 
genetics and reproductive medicine as well as resulting in 
the European Human Rights Legislation39 – the first 16 
years of the 21st century with regards to health prevention 
policy decisions have gradually brought to public attention 
new important questions about the formation of /compliance 
with emerging standards of PHE. Having in its constitution 
an article on the inviolability of human dignity, Germany 
has made a considerable step towards a health policy focus 
of prevention and health promotion since the turn of the 
millennium. As the effects of these public health decisions 
will gradually show over mid- and long-term periods, both 
in terms of improvements in individual health outcome 
and concurrently in diagnostics or therapies on the level of 
the individual patient, new concepts are needed for easing 
ethical evaluations of public health measures. Evidence based 
prevention policies will increasingly emerge99 and along with 
them a stronger need for applicable bioethical standards.54 
In addition to this, novel information technology tools allow 
for better direct involvement and active participatory role of 
patients in biomedicine and clinical research.100
The debate about ‘Health and Human Rights,’ which started 
with the turn of the millennium101 in succession of the 
completion of the Oviedo-Convention,39 has also highlighted 
the value of the concept of respect for human dignity in the 
bioethical debate9; this has already led to new perceptions and 
concepts in clinical bioethics.26 
Complementary to this, human dignity, in addition to the 
biomedical principles, can also serve as a valuable criterion for 
ethical case analysis in the public health sector. Strengthening 
the focus on Human Dignity, ie, integration of this criterion 
as a genuine part of public health policy evaluation in 
bioethical terms would thus be a worthwhile addition to 
current PHE debates. Importantly, an endorsement of 
human rights in the public health sector should ideally be 
accompanied by an extension of this concept not just to 
state legislation and health law, but also to the broad sector 
of non-governmental organizations (NGOs) and healthcare 
professional legislation.97 Finally, utilizing global health 
innovation technology models,102 successful regional health 
policy concepts have to be aligned with policies of neighbor 
states103 and ultimately transferred to the global level. 
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